Parkinson's Disease In The Crossfire 2008


2008 Webcasts

New information for neurologists and other medical professionals broadcast from the Crossfire Studio in Washington, DC.

Focus on Neuroprotection 2008

Focus on Neuroprotection 2008

1 hour

Recorded: January 25, 2008
Release Date: July 1, 2008
Expiration Date: July 1, 2010
CME Information

Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.

How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.

Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:

  • Discuss current concepts related to the etiology and pathogenesis of Parkinson's Disease
  • Identify candidate targets and agents for putative neuroprotective drugs
  • Identify the positive and negative clinical trials that have been performed to date
  • Identify obstacles to development of a neuroprotective therapy

Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.

This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.

Focus on Treatment 2008

Focus on Treatment 2008

1 hour

Recorded: January 25, 2008
Release Date: April 1, 2008
Expiration Date: April 1, 2010
CME Information

Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.

How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.

Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:

  • Discuss the importance of early diagnosis in terms of effective treatment
  • Differentiate the treatment options available for initial treatment of Parkinson's Disease
  • Discuss the management of motor complications and identify different treatment modalities
  • Identify non-motor features of Parkinson's Disease and their significance in Parkinson's Disease

Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.

This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Astute Technology.